申请人:Van Der Geize Robert
公开号:US20120058977A1
公开(公告)日:2012-03-08
A pharmaceutical composition for the treatment of a disease caused by a bacterium that belongs to the group of nocardioform actinomycetes, said composition comprising an effective amount of a compound selected from compound I, (+)-compound II, (−)-compound II, compound III, or mixtures thereof.
一种用于治疗由属于诺卡菌类放线菌菌群的细菌引起的疾病的药物组合物,该组合物包括从化合物I、(+)-化合物II、(-)-化合物II、化合物III或它们的混合物中选择的有效量化合物。